Back to Search
Start Over
SARS-CoV-2 and hepatitis.
- Source :
-
Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2020 Sep 09; Vol. 29 (3), pp. 473-475. Date of Electronic Publication: 2020 Sep 09. - Publication Year :
- 2020
- Subjects :
- Antiviral Agents administration & dosage
Antiviral Agents adverse effects
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques methods
Diagnosis, Differential
Drug Combinations
Humans
Liver pathology
Liver Function Tests methods
Male
Middle Aged
SARS-CoV-2
COVID-19 Drug Treatment
Alanine Transaminase blood
Aspartate Aminotransferases blood
Betacoronavirus isolation & purification
Betacoronavirus pathogenicity
Chemical and Drug Induced Liver Injury blood
Chemical and Drug Induced Liver Injury diagnosis
Chemical and Drug Induced Liver Injury etiology
Chloroquine administration & dosage
Chloroquine adverse effects
Coronavirus Infections complications
Coronavirus Infections diagnosis
Coronavirus Infections drug therapy
Coronavirus Infections physiopathology
Hepatitis, Viral, Human blood
Hepatitis, Viral, Human diagnosis
Hepatitis, Viral, Human etiology
Lopinavir administration & dosage
Lopinavir adverse effects
Pandemics
Pneumonia, Viral complications
Pneumonia, Viral diagnosis
Pneumonia, Viral physiopathology
Ritonavir administration & dosage
Ritonavir adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1842-1121
- Volume :
- 29
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of gastrointestinal and liver diseases : JGLD
- Publication Type :
- Report
- Accession number :
- 32919428
- Full Text :
- https://doi.org/10.15403/jgld-2747